Showing results (611-620 of 3,150) with videos related to

Sort By:
Pageof 315
Neuro-Oncology|November 2, 2012
Detection of glioblastoma response to temozolomide combined with bevacizumab based on μMRI and μPET imaging reveals [18F]-fluoro-L-thymidine as an early and robust predictive marker for treatment efficacyAurélien Corroyer-Dulmont, Elodie A Pérès, Edwige Petit, et al.
Neuro-Oncology|January 28, 2014
Silencing of protein kinase D2 induces glioma cell senescence via p53-dependent and -independent pathwaysEva Bernhart, Sabine Damm, Petra Heffeter, et al.
Neuro-Oncology|January 28, 2014
MiR-196a exerts its oncogenic effect in glioblastoma multiforme by inhibition of IκBα both in vitro and in vivoGuang Yang, Dayong Han, Xin Chen, et al.
Neuro-Oncology|May 28, 2014
JAK2/STAT3 targeted therapy suppresses tumor invasion via disruption of the EGFRvIII/JAK2/STAT3 axis and associated focal adhesion in EGFRvIII-expressing glioblastomaQifan Zheng, Lei Han, Yucui Dong, et al.
Neuro-Oncology|May 28, 2014
MiR-124 governs glioma growth and angiogenesis and enhances chemosensitivity by targeting R-Ras and N-RasZhumei Shi, Qiudan Chen, Chongyong Li, et al.
Neuro-Oncology|January 29, 2014
Analysis of IDH mutation, 1p/19q deletion, and PTEN loss delineates prognosis in clinical low-grade diffuse gliomasNesrin Sabha, Christiane B Knobbe, Majula Maganti, et al.
Neuro-Oncology|January 29, 2014
Incidence and survival of children with central nervous system primitive tumors in the French National Registry of Childhood Solid TumorsEmmanuel Desandes, Sandra Guissou, Pascal Chastagner, et al.
Neuro-Oncology|January 29, 2014
Phase I/II study of erlotinib and temsirolimus for patients with recurrent malignant gliomas: North American Brain Tumor Consortium trial 04-02Patrick Y Wen, Susan M Chang, Kathleen R Lamborn, et al.
Neuro-Oncology|October 24, 2012
The molecular biology of WHO grade I astrocytomasNicholas F Marko, Robert J Weil
Neuro-Oncology|February 9, 2022
Serial H3K27M cell-free tumor DNA (cf-tDNA) tracking predicts ONC201 treatment response and progression in diffuse midline gliomaEvan Cantor, Kyle Wierzbicki, Rohinton S Tarapore, et al.
Pageof 315